Meet the media team
Find a media contact in your region
Total 30 Results for:
Showing 24 out of 30 results
20 August 2021
Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised neuro-interventional medical device manufacturer Shanghai HeartCare Medial Technology …
18 June 2021
Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
9 April 2021
Herbert Smith Freehills advises Rosemary Health on Series Seed-2 capital raise
Herbert Smith Freehills’ Venture Capital team has advised Rosemary Health on its Series Seed-2 capital raise.Rosemary Health is a telehealth platform …
24 February 2021
Australian IPOs defy early expectations to achieve record end to 2020
The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
7 December 2020
Hiswara Bunjamin & Tandjung advises PT Omni Healthcare on sale of controlling stake in PT Sarana Meditama Metropolitan Tbk
Leading Indonesian law firm Hiswara Bunjamin & Tandjung (HBT) has advised Indonesian hospital group PT Omni Healthcare on the sale of its controlling …
20 November 2020
Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
29 October 2020
Herbert Smith Freehills advises Rosemary Health on Series Seed capital raise
Herbert Smith Freehills’ venture capital team has advised Rosemary Health on its Series Seed capital raise.Rosemary Health is telehealth platform that …
27 October 2020
Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
8 July 2020
Herbert Smith Freehills’ finance team advises Crescent Capital Partners on acquisition of PRP Group
Herbert Smith Freehills has advised Crescent Capital Partners on the debt financing aspects of its acquisition of PRP Group. Crescent has been the most …
17 June 2020
Herbert Smith Freehills advises Healius on the sale of its medical and dental centres business
Herbert Smith Freehills’ M&A team has advised Healius Limited on the sale of its medical and dental centres business, with an enterprise value of …
25 May 2020
Herbert Smith Freehills advises Ramsay Health Care Limited on its capital raising
Herbert Smith Freehills has advised Ramsay Health Care Limited (Ramsay Health Care) on its capital raising, comprising a fully underwritten A$1,200 …
15 May 2020
Herbert Smith Freehills advises sponsors on Peijia Medical’s HK$2.34 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为沛嘉医疗23.4亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors of medical device …
Showing 24 out of 30 results
View moreSearchlight AI
Our new tracking tool keeps you current with developments in artificial intelligence in all major markets